Ernexa Therapeutics Inc. Share-based Payment Arrangement, Expense
Ernexa Therapeutics Inc. (ERNA) reported Share-based Payment Arrangement, Expense of $320.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- Ernexa Therapeutics Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $320.00K, a 13.04% decline year-over-year.
- Ernexa Therapeutics Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $308.00K, a 38.65% decline year-over-year.
- Ernexa Therapeutics Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $333.00K, a 18.78% decline year-over-year.
- Ernexa Therapeutics Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $293.00K, a 27.65% decline year-over-year.
- Ernexa Therapeutics Inc. share-based payment arrangement, expense for fiscal 2025 was $1.50M, a 1.58% decline from fiscal 2024.
- Ernexa Therapeutics Inc. share-based payment arrangement, expense for fiscal 2024 was $1.52M, a 22.38% increase from fiscal 2023.
- Ernexa Therapeutics Inc. share-based payment arrangement, expense for fiscal 2023 was $1.24M, a 57.68% decline from fiscal 2022.
- Ernexa Therapeutics Inc. share-based payment arrangement, expense for fiscal 2022 was $2.94M, a 43.94% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $320.00K 10-Q · filed 2026-08-06 | $629.00K 10-Q · filed 2026-08-06 | $961.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.25M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $308.00K 10-Q · filed 2026-05-11 | $641.00K derived: sum of 2 quarters · filed 2026-05-11 | $934.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.30M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $626.00K derived: sum of 2 quarters · filed 2026-03-13 | $994.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.50M 10-K · filed 2026-03-13 | |||
| 2025-09-30 | $293.00K 10-Q · filed 2025-11-07 | $661.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.16M 10-Q · filed 2025-11-07 | $1.57M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $368.00K 10-Q · filed 2026-08-06 | $870.00K 10-Q · filed 2026-08-06 | $1.28M derived: sum of 3 quarters · filed 2026-08-06 | $1.69M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $502.00K 10-Q · filed 2026-05-11 | $912.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.32M derived: sum of 3 quarters · filed 2026-05-11 | $1.74M derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $815.00K derived: sum of 2 quarters · filed 2026-03-13 | $1.24M derived: sum of 3 quarters · filed 2026-03-13 | $1.52M 10-K · filed 2026-03-13 | |||
| 2024-09-30 | $405.00K 10-Q · filed 2025-11-07 | $828.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.11M 10-Q · filed 2025-11-07 | $1.27M derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $423.00K 10-Q · filed 2025-08-13 | $705.00K 10-Q · filed 2025-08-13 | $870.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.04M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $282.00K 10-Q · filed 2025-05-07 | $447.00K derived: sum of 2 quarters · filed 2025-05-07 | $621.00K derived: sum of 3 quarters · filed 2025-05-07 | $835.00K derived: sum of 4 quarters · filed 2025-05-07 | |||
| 2023-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $339.00K derived: sum of 2 quarters · filed 2025-03-12 | $553.00K derived: sum of 3 quarters · filed 2025-03-12 | $1.24M 10-K · filed 2025-03-12 | |||
| 2023-09-30 | $174.00K 10-Q · filed 2024-11-12 | $388.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.08M 10-Q · filed 2024-11-12 | $1.47M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $214.00K 10-Q · filed 2024-08-13 | $903.00K 10-Q · filed 2024-08-13 | $1.30M derived: sum of 3 quarters · filed 2024-08-13 | $1.78M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | $689.00K 10-Q · filed 2024-05-14 | $1.09M derived: sum of 2 quarters · filed 2024-05-14 | $1.56M derived: sum of 3 quarters · filed 2024-05-14 | $2.44M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $397.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $873.00K derived: sum of 2 quarters · filed 2024-03-14 | $1.75M derived: sum of 3 quarters · filed 2024-03-14 | $2.94M 10-K · filed 2024-03-14 | |||
| 2022-09-30 | $476.00K 10-Q · filed 2023-11-13 | $1.35M derived: sum of 2 quarters · filed 2023-11-13 | $2.54M 10-Q · filed 2023-11-13 | $4.47M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $879.00K 10-Q · filed 2023-08-11 | $2.06M 10-Q · filed 2023-08-11 | $4.00M derived: sum of 3 quarters · filed 2023-08-11 | $5.72M derived: sum of 4 quarters · filed 2023-08-11 | |||
| 2022-03-31 | $1.18M 10-Q · filed 2023-05-11 | $3.12M derived: sum of 2 quarters · filed 2023-05-11 | $4.84M derived: sum of 3 quarters · filed 2023-05-11 | $6.00M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $3.66M derived: sum of 2 quarters · filed 2023-03-20 | $4.82M derived: sum of 3 quarters · filed 2023-03-20 | $5.24M 10-K · filed 2023-03-20 | |||
| 2021-09-30 | $1.73M 10-Q · filed 2022-11-14 | $1.73M 10-Q · filed 2021-11-12 | $2.88M derived: sum of 2 quarters · filed 2022-11-14 | $3.30M 10-Q · filed 2022-11-14 | $3.30M 10-Q · filed 2021-11-12 | $3.07M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $1.15M 10-Q · filed 2022-08-11 | $1.15M 10-Q · filed 2021-08-13 | $1.57M 10-Q · filed 2022-08-11 | $1.57M 10-Q · filed 2021-08-13 | $1.35M derived: sum of 3 quarters · filed 2022-08-11 | $1.37M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $169.00K 10-Q · filed 2021-05-17 | $191.79K derived: sum of 2 quarters · filed 2022-07-01 | $214.53K derived: sum of 3 quarters · filed 2022-07-01 | $237.26K derived: sum of 4 quarters · filed 2022-07-01 | |||
| 2020-12-31 | $22.80K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | $45.53K derived: sum of 2 quarters · filed 2022-07-01 | $68.27K derived: sum of 3 quarters · filed 2022-07-01 | $91.00K 10-K/A · filed 2022-07-01 | |||
| 2020-09-30 | $22.73K 10-Q · filed 2021-11-12 | $45.47K derived: sum of 2 quarters · filed 2021-11-12 | $68.20K 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | $22.73K 10-Q · filed 2021-08-13 | $45.47K 10-Q · filed 2021-08-13 | |||||
| 2020-03-31 | $22.73K 10-Q · filed 2021-05-17 | ||||||
| 2015-03-31 | $99.00K 10-Q · filed 2015-05-08 | ||||||
| 2014-03-31 | $52.00K 10-Q · filed 2015-05-08 | ||||||
| 2013-12-31 | $132.00K 10-K · filed 2014-03-31 | ||||||
| 2012-12-31 | $185.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |